Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
983 Views
Thomson Medical – Limited Impact from Proposed Distribution of RE Business. Still Looks Expensive.
Thomson Medical Group f.k.a. Rowsley Ltd (ROWS SP) (“TMG”), a SGX-listed healthcare and property developer, announced this morning that it plans to...
376 Views
Qualitas Medical Group IPO Review - Valuation up 95% in One Month
Qualitas Medical Group (QMGL SP) is looking to raise approximately US$102m in its upcoming IPO. The company will be using the proceeds to make...
519 Views
The Week that Was in ASEAN@Smartkarma - Consumer Finance, Political Scenarios and Indonesian Banks
This week's offering across ASEAN@Smartkarma is as always an eclectic mix of both top-down and thematic insights, as well as equity bottom up. I...
183 Views
Signs of Irrational Exuberance as Rowsley Transforms into Thomson Medical
Rowsley Ltd (ROWS SP) announced that earlier in July that it will be buying Sasteria, the company that holds Thomson Medical. On 18th December, the...
323 Views